Viking Therapeutics, Inc. (VKTX)
NASDAQ: VKTX · Real-Time Price · USD
51.53
+0.02 (0.04%)
At close: Nov 20, 2024, 4:00 PM
51.80
+0.27 (0.52%)
Pre-market: Nov 21, 2024, 5:41 AM EST
Viking Therapeutics Stock Forecast
Stock Price Forecast
The 10 analysts with 12-month price forecasts for Viking Therapeutics stock have an average target of 109.8, with a low estimate of 80 and a high estimate of 138. The average target predicts an increase of 113.08% from the current stock price of 51.53.
Analyst Consensus: Strong Buy
Analyst Ratings
The average analyst rating for VKTX stock from 10 stock analysts is "Strong Buy". This means that analysts believe this stock is likely to perform very well in the near future and significantly outperform the market.
Recommendation Trends
| Rating | Jun '24 | Jul '24 | Aug '24 | Sep '24 | Oct '24 | Nov '24 |
|---|---|---|---|---|---|---|
| Strong Buy | 7 | 7 | 7 | 7 | 7 | 7 |
| Buy | 2 | 2 | 2 | 3 | 3 | 3 |
| Hold | 0 | 0 | 0 | 0 | 0 | 0 |
| Sell | 0 | 0 | 0 | 0 | 0 | 0 |
| Strong Sell | 0 | 0 | 0 | 0 | 0 | 0 |
| Total | 9 | 9 | 9 | 10 | 10 | 10 |
Latest Forecasts
| Analyst | Firm | Rating | Rating | Action | Price Target | Upside | Date |
|---|---|---|---|---|---|---|---|
| HC Wainwright & Co. | HC Wainwright & Co. | Strong Buy Maintains $90 → $102 | Strong Buy | Maintains | $90 → $102 | +97.94% | Nov 5, 2024 |
| HC Wainwright & Co. | HC Wainwright & Co. | Strong Buy Reiterates $90 | Strong Buy | Reiterates | $90 | +74.66% | Oct 24, 2024 |
| HC Wainwright & Co. | HC Wainwright & Co. | Strong Buy Reiterates $90 | Strong Buy | Reiterates | $90 | +74.66% | Oct 9, 2024 |
| Oppenheimer | Oppenheimer | Buy Reiterates $138 | Buy | Reiterates | $138 | +167.81% | Sep 25, 2024 |
| Morgan Stanley | Morgan Stanley | Buy Reiterates $105 | Buy | Reiterates | $105 | +103.76% | Sep 12, 2024 |
Financial Forecast
Revenue This Year
n/a
Revenue Next Year
2.55M
EPS This Year
-1.00
from -0.91
EPS Next Year
-1.54
from -1.00
Revenue Forecast
| Revenue | 2024 | 2025 | 2026 | 2027 | 2028 |
|---|---|---|---|---|---|
| High | n/a | 26.3M | 200.7M | ||
| Avg | n/a | 2.6M | 26.4M | ||
| Low | n/a | n/a | n/a |
Revenue Growth
| Revenue Growth | 2024 | 2025 | 2026 | 2027 | 2028 |
|---|---|---|---|---|---|
| High | - | - | 7,771.8% | ||
| Avg | - | - | 934.1% | ||
| Low | - | - | - |
EPS Forecast
| EPS | 2024 | 2025 | 2026 | 2027 | 2028 |
|---|---|---|---|---|---|
| High | -0.83 | -1.21 | -0.34 | ||
| Avg | -1.00 | -1.54 | -1.79 | ||
| Low | -1.27 | -2.03 | -2.65 |
EPS Growth
| EPS Growth | 2024 | 2025 | 2026 | 2027 | 2028 |
|---|---|---|---|---|---|
| High | - | - | - | ||
| Avg | - | - | - | ||
| Low | - | - | - |
Sources: Price targets and analyst ratings provided by Benzinga. Revenue and EPS forecast data provided by Finnhub. The data is sourced from Wall Street analysts. Data disclaimer.